Abstract
Numerous systems and organs are affected by stress. In this review we will focus on the effects in brain. Some of the most impressive effects of the stress in brain are the atrophy of hippocampal dendrites or even the reduction of the hippocampal size observed in brains from subjects exposed to severe or chronic stress. Obviously, before reaching this point of damage there are many other processes taking place in the stressed CNS. The release of glucocorticoids is one of the first features of the stress response. Glucocorticoids can result in neurotoxicity through different mechanisms, including modifications in the energy metabolism or via an increase in excitatory amino acids such as glutamate in the extracellular space. Glutamate can induce neuronal excitotoxicity. This sequence of events leads to the activation of TNFα convertase (TACE) and TNFα release in brain of rats subjected to restraint stress. One of the multiple effects exerted by this cytokine is to initiate the translocation of the transcription factor NFκB to neuronal nuclei. NFκB activation results in the induction of iNOS and COX2, two enzymes responsible for a great portion of the neurological damage produced in models of stress.
Keywords: ACTH, superoxide dismutase, NMDA, cytokines, transcription factor family, NOS isoenzyme
CNS & Neurological Disorders - Drug Targets
Title: Stress-Induced Oxidative Changes in Brain
Volume: 5 Issue: 5
Author(s): Jose L. M. Madrigal, Borja Garcia-Bueno, Javier R. Caso, Beatriz G. Perez-Nievas and Juan C. Leza
Affiliation:
Keywords: ACTH, superoxide dismutase, NMDA, cytokines, transcription factor family, NOS isoenzyme
Abstract: Numerous systems and organs are affected by stress. In this review we will focus on the effects in brain. Some of the most impressive effects of the stress in brain are the atrophy of hippocampal dendrites or even the reduction of the hippocampal size observed in brains from subjects exposed to severe or chronic stress. Obviously, before reaching this point of damage there are many other processes taking place in the stressed CNS. The release of glucocorticoids is one of the first features of the stress response. Glucocorticoids can result in neurotoxicity through different mechanisms, including modifications in the energy metabolism or via an increase in excitatory amino acids such as glutamate in the extracellular space. Glutamate can induce neuronal excitotoxicity. This sequence of events leads to the activation of TNFα convertase (TACE) and TNFα release in brain of rats subjected to restraint stress. One of the multiple effects exerted by this cytokine is to initiate the translocation of the transcription factor NFκB to neuronal nuclei. NFκB activation results in the induction of iNOS and COX2, two enzymes responsible for a great portion of the neurological damage produced in models of stress.
Export Options
About this article
Cite this article as:
M. Madrigal L. Jose, Garcia-Bueno Borja, Caso R. Javier, Perez-Nievas G. Beatriz and Leza C. Juan, Stress-Induced Oxidative Changes in Brain, CNS & Neurological Disorders - Drug Targets 2006; 5 (5) . https://dx.doi.org/10.2174/187152706778559327
DOI https://dx.doi.org/10.2174/187152706778559327 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Approaches to Mitochondrial Gene Therapy
Current Gene Therapy Gene Therapy for Ischemic Brain Diseases
Current Gene Therapy Mathematical Modelling and Feature Extraction for Probing Crucial Changes Associated with Alzheimers Disease
Current Medical Imaging Prorenin and the (Pro)renin Receptor in Retinal Pathology
Current Hypertension Reviews Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease
Current Medicinal Chemistry Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
Current Medicinal Chemistry Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Teratogenic Activity of HDAC Inhibitors
Current Pharmaceutical Design Transcranial Magnetic Stimulation on Rodent Models
CNS & Neurological Disorders - Drug Targets Oxidative Damage Impact on Aging and Age-Related Diseases: Drug Targeting of Telomere Attrition and Dynamic Telomerase Activity Flirting with Imidazole-Containing Dipeptides
Recent Patents on Drug Delivery & Formulation Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer’s Disease
Current Alzheimer Research Brain Magnetic Stimulation in Animal Models: A Valuable Lesson for Clinical Applications
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
Current Neuropharmacology Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design Patent Selections
Recent Patents on Computer Science Synthesis and Anticonvulsant Activity of Some Cinnamylpiperazine Derivatives
Letters in Drug Design & Discovery An Update on Autoinflammatory Diseases
Current Medicinal Chemistry Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis
Current Neuropharmacology